全文获取类型
收费全文 | 31281篇 |
免费 | 2575篇 |
国内免费 | 90篇 |
专业分类
耳鼻咽喉 | 534篇 |
儿科学 | 1257篇 |
妇产科学 | 1013篇 |
基础医学 | 4245篇 |
口腔科学 | 843篇 |
临床医学 | 2720篇 |
内科学 | 7197篇 |
皮肤病学 | 744篇 |
神经病学 | 3233篇 |
特种医学 | 1143篇 |
外国民族医学 | 3篇 |
外科学 | 3880篇 |
综合类 | 536篇 |
一般理论 | 43篇 |
预防医学 | 2275篇 |
眼科学 | 629篇 |
药学 | 1772篇 |
中国医学 | 8篇 |
肿瘤学 | 1871篇 |
出版年
2021年 | 349篇 |
2020年 | 270篇 |
2019年 | 451篇 |
2018年 | 501篇 |
2017年 | 360篇 |
2016年 | 404篇 |
2015年 | 471篇 |
2014年 | 651篇 |
2013年 | 972篇 |
2012年 | 1266篇 |
2011年 | 1336篇 |
2010年 | 794篇 |
2009年 | 691篇 |
2008年 | 1223篇 |
2007年 | 1330篇 |
2006年 | 1304篇 |
2005年 | 1236篇 |
2004年 | 1232篇 |
2003年 | 1124篇 |
2002年 | 1194篇 |
2001年 | 1102篇 |
2000年 | 1165篇 |
1999年 | 966篇 |
1998年 | 352篇 |
1997年 | 288篇 |
1996年 | 285篇 |
1995年 | 301篇 |
1994年 | 292篇 |
1993年 | 311篇 |
1992年 | 860篇 |
1991年 | 810篇 |
1990年 | 681篇 |
1989年 | 733篇 |
1988年 | 684篇 |
1987年 | 709篇 |
1986年 | 657篇 |
1985年 | 680篇 |
1984年 | 540篇 |
1983年 | 462篇 |
1982年 | 296篇 |
1980年 | 260篇 |
1979年 | 452篇 |
1978年 | 303篇 |
1977年 | 258篇 |
1976年 | 280篇 |
1975年 | 266篇 |
1974年 | 296篇 |
1973年 | 293篇 |
1972年 | 266篇 |
1971年 | 260篇 |
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
1.
Osnat Bairey MD Alisa Taliansky MD Amir Glik MD Alexandra Amiel MD Shlomit Yust-Katz MD Ronit Gurion MD Miri Zektser MD Tzvika Porges MD Nadav Sarid MD Netanel A. Horowitz MD Tzahala Tzuk Shina MD Eyal Lebel MD Amos Cohen MD Karyn Revital Geiger MD Pia Raanani MD Ofir Wolach MD Tali Siegal MD 《Cancer》2023,129(24):3905-3914
2.
Suzanne C. Danhauer PhD Elizabeth L. Addington PhD Lorenzo Cohen PhD Stephanie J. Sohl PhD Marieke Van Puymbroeck PhD Natalia K. Albinati S. Nicole Culos-Reed PhD 《Cancer》2019,125(12):1979-1989
Because yoga is increasingly recognized as a complementary approach to cancer symptom management, patients/survivors and providers need to understand its potential benefits and limitations both during and after treatment. The authors reviewed randomized controlled trials (RCTs) of yoga conducted at these points in the cancer continuum (N = 29; n = 13 during treatment, n = 12 post-treatment, and n = 4 with mixed samples). Findings both during and after treatment demonstrated the efficacy of yoga to improve overall quality of life (QOL), with improvement in subdomains of QOL varying across studies. Fatigue was the most commonly measured outcome, and most RCTs conducted during or after cancer treatment reported improvements in fatigue. Results also suggested that yoga can improve stress/distress during treatment and post-treatment disturbances in sleep and cognition. Several RCTs provided evidence that yoga may improve biomarkers of stress, inflammation, and immune function. Outcomes with limited or mixed findings (eg, anxiety, depression, pain, cancer-specific symptoms, such as lymphedema) and positive psychological outcomes (such as benefit-finding and life satisfaction) warrant further study. Important future directions for yoga research in oncology include: enrolling participants with cancer types other than breast, standardizing self-report assessments, increasing the use of active control groups and objective measures, and addressing the heterogeneity of yoga interventions, which vary in type, key components (movement, meditation, breathing), dose, and delivery mode. 相似文献
3.
4.
5.
Introduction
The Advisory Committee on Immunization Practices (ACIP) has focused on maternal Tdap immunization as an important means to protect neonates from pertussis infections. There is little published data on provider and/or clinic characteristics as predictors of maternal Tdap uptake. This study examined differences in maternal Tdap coverage in women delivering at a single academic institution, but cared for prenatally in different clinical settings, in 2013, 2014, and 2015. Additionally, the accuracy and utilization of Vermont's immunization information system (IIS) was assessed.Methods
This was a retrospective, multiple time-point cross-sectional analysis of annual maternal Tdap coverage in women delivering at a single academic institution in the 3?years following a fundamental change in national maternal Tdap vaccination guidelines. Tdap administration was examined across different obstetric groups using chart review and data from the state's IIS.Results
All obstetric care groups except the resident-staffed clinic significantly increased maternal Tdap coverage in 2014, compared to 2013 coverage, with no further increase in 2015. In contrast, there was no increase in maternal Tdap coverage in 2014 in the resident-staffed clinics, but then a statistically significant increase in 2015. Overall Tdap coverage in 2014 was 80.4%, with variation in Tdap coverage between clinics types. In the subset of women who were cared for by the University-based groups, there was significant variation in Tdap coverage between clinics, despite racial homogeneity, which persisted after adjustment for maternal age and insurance type. The state's IIS was found to be highly accurate, using individual chart review as the “gold standard.”Discussion
While we demonstrated high maternal Tdap coverage in women delivering at our institution, differences in clinic type and provider training appeared to impact immunization rates, as well as how quickly evolving national recommendations were adopted. Additionally, the fidelity of the state's IIS data was verified. 相似文献6.
7.
Nicole D. Facompre Pavithra Rajagopalan Varun Sahu Alexander T. Pearson Kathleen T. Montone Claire D. James Frederico O. Gleber-Netto Gregory S. Weinstein Jalal Jalaly Alexander Lin Anil K. Rustgi Hiroshi Nakagawa Joseph A. Califano Curtis R. Pickering Elizabeth A. White Bradford E. Windle Iain M. Morgan Roger B. Cohen Phyllis A. Gimotty Devraj Basu 《International journal of cancer. Journal international du cancer》2020,147(11):3236-3249
8.
N. Shor R. Deschamps A. Cobo Calvo E. Maillart H. Zephir J. Ciron C. Papeix F. Durand-Dubief A. Ruet X. Ayrignac M. Cohen K. Deiva D. Laplaud B. Bourre B. Audoin N. Collongues S. Vukusic F. Cotton R. Marignier 《Revue neurologique》2021,177(1-2):39-50
Our knowledge of the radiological spectrum of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is growing rapidly. An update on the radiological features of the disease, and its evolution is thus necessary. Magnetic resonance imaging (MRI) has an increasingly important role in the differential diagnosis of MOGAD particularly from aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and multiple sclerosis (MS). Differentiating these conditions is of prime importance because the management is different between the three inflammatory diseases, and thus could prevent further attack-related disability. Therefore, identifying the MRI features suggestive of MOGAD has diagnostic and prognostic implications. We herein review optic nerve, spinal cord and the brain MRI findings from MOGAD adult patients, and compare them to AQP4-NMOSD and MS. 相似文献
9.
10.